Suppr超能文献

微小病变病复发患者的肾小球内皮细胞和足细胞可表达CD80。

Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse.

作者信息

Cara-Fuentes Gabriel, Venkatareddy Madhusudan, Verma Rakesh, Segarra Alfons, Cleuren Audrey C, Martínez-Ramos Alfonso, Johnson Richard J, Garg Puneet

机构信息

Division of Pediatric Nephrology, Department of Pediatrics, University of Michigan, MSRB-2, Room 1574, 1500 E Medical Center Dr, Ann Arbor, MI, 48109, USA.

Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, USA.

出版信息

Pediatr Nephrol. 2020 Oct;35(10):1887-1896. doi: 10.1007/s00467-020-04541-3. Epub 2020 May 12.

Abstract

BACKGROUND

Urinary CD80 has emerged as potential biomarker in idiopathic nephrotic syndrome (INS). However, its cellular source remains controversial. The aim of the study was to assess whether CD80 is truly expressed by glomerular cells in INS patients during relapse and in the LPS mouse model of podocyte injury.

METHODS

The presence of CD80 in glomeruli was evaluated by combining immunostaining, immunogold labeling, and in situ hybridization techniques.

RESULTS

CD80 was present along the surface of glomerular endothelial cells (GEC) and rarely in podocytes in six of nine minimal change disease (MCD) patients in relapse, two of eleven patients with focal segmental glomerulosclerosis in relapse, and absent in controls. In mice, CD80 was upregulated at mRNA and protein level in GEC and podocytes, in a similar pattern to that seen in MCD patients.

CONCLUSIONS

Glomerular endothelial cells and podocytes can express CD80 in patients with MCD during relapse. A better understanding of the role of CD80 in glomerular cells may provide further insights into the mechanisms of proteinuria in INS.

摘要

背景

尿CD80已成为特发性肾病综合征(INS)的潜在生物标志物。然而,其细胞来源仍存在争议。本研究的目的是评估在复发期间的INS患者以及足细胞损伤的脂多糖小鼠模型中,肾小球细胞是否真的表达CD80。

方法

通过结合免疫染色、免疫金标记和原位杂交技术评估肾小球中CD80的存在情况。

结果

在9例复发的微小病变病(MCD)患者中的6例、11例复发的局灶节段性肾小球硬化患者中的2例中,CD80存在于肾小球内皮细胞(GEC)表面,在足细胞中很少见,而在对照组中不存在。在小鼠中,GEC和足细胞中的CD80在mRNA和蛋白质水平上上调,其模式与MCD患者中所见相似。

结论

复发期间MCD患者的肾小球内皮细胞和足细胞可表达CD80。更好地了解CD80在肾小球细胞中的作用可能会为INS中蛋白尿的机制提供进一步的见解。

相似文献

8
Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis?微小病变病:足细胞CD80 - CTLA - 4轴的失调?
Pediatr Nephrol. 2014 Dec;29(12):2333-40. doi: 10.1007/s00467-014-2874-8. Epub 2014 Jul 14.
10
Maximal 'CD80-uria' with minimal change.最大程度的“CD80-尿”与最小变化。
Kidney Int. 2010 Aug;78(3):236-8. doi: 10.1038/ki.2010.148.

引用本文的文献

9
An updated view of the pathogenesis of steroid-sensitive nephrotic syndrome.类固醇敏感性肾病综合征发病机制的最新观点。
Pediatr Nephrol. 2022 Sep;37(9):1957-1965. doi: 10.1007/s00467-021-05401-4. Epub 2022 Jan 10.
10
Molecular Mechanisms of Proteinuria in Minimal Change Disease.微小病变性肾病蛋白尿的分子机制
Front Med (Lausanne). 2021 Dec 23;8:761600. doi: 10.3389/fmed.2021.761600. eCollection 2021.

本文引用的文献

1
The in vivo endothelial cell translatome is highly heterogeneous across vascular beds.血管床间内皮细胞翻译组高度异质性。
Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23618-23624. doi: 10.1073/pnas.1912409116. Epub 2019 Nov 11.
2
Abatacept in Steroid-Dependent Minimal Change Disease and CD80-uria.阿巴西普治疗类固醇依赖型微小病变病及CD80尿症
Kidney Int Rep. 2019 May 31;4(9):1349-1353. doi: 10.1016/j.ekir.2019.05.1155. eCollection 2019 Sep.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验